These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 35253361)

  • 21. Late transplant-associated thrombotic microangiopathy verified in bone marrow biopsy specimens is associated with chronic GVHD and viral infections.
    Hill W; Sotlar K; Hautmann A; Kolb HJ; Ullmann J; Hausmann A; Schmidt M; Tischer J; Pham TT; Rank A; Hoechstetter MA
    Eur J Haematol; 2024 May; 112(5):819-831. PubMed ID: 38243840
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Management of transplant-associated thrombotic microangiopathy].
    Ikezoe T
    Rinsho Ketsueki; 2018; 59(10):2307-2314. PubMed ID: 30305540
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Early Elevation of Complement Factor Ba Is a Predictive Biomarker for Transplant-Associated Thrombotic Microangiopathy.
    Okamura H; Nakamae H; Shindo T; Ohtani K; Hidaka Y; Ohtsuka Y; Makuuchi Y; Kuno M; Takakuwa T; Harada N; Nishimoto M; Nakashima Y; Koh H; Hirose A; Nakamae M; Wakamiya N; Hino M; Inoue N
    Front Immunol; 2021; 12():695037. PubMed ID: 34326846
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Emerging therapeutic and preventive approaches to transplant-associated thrombotic microangiopathy.
    Schoettler M; Chonat S; Williams K; Lehmann L
    Curr Opin Hematol; 2021 Nov; 28(6):408-416. PubMed ID: 34534983
    [TBL] [Abstract][Full Text] [Related]  

  • 25. New approaches in the diagnosis, pathophysiology, and treatment of pediatric hematopoietic stem cell transplantation-associated thrombotic microangiopathy.
    Jodele S; Dandoy CE; Myers KC; El-Bietar J; Nelson A; Wallace G; Laskin BL
    Transfus Apher Sci; 2016 Apr; 54(2):181-90. PubMed ID: 27156964
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Serum neutrophil extracellular trap levels predict thrombotic microangiopathy after allogeneic stem cell transplantation.
    Arai Y; Yamashita K; Mizugishi K; Watanabe T; Sakamoto S; Kitano T; Kondo T; Kawabata H; Kadowaki N; Takaori-Kondo A
    Biol Blood Marrow Transplant; 2013 Dec; 19(12):1683-9. PubMed ID: 24055655
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Interferon-complement loop in transplant-associated thrombotic microangiopathy.
    Jodele S; Medvedovic M; Luebbering N; Chen J; Dandoy CE; Laskin BL; Davies SM
    Blood Adv; 2020 Mar; 4(6):1166-1177. PubMed ID: 32208488
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Transplant-Associated Thrombotic Microangiopathy in Pediatric Hematopoietic Cell Transplant Recipients: A Practical Approach to Diagnosis and Management.
    Dvorak CC; Higham C; Shimano KA
    Front Pediatr; 2019; 7():133. PubMed ID: 31024873
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A pragmatic multi-institutional approach to understanding transplant-associated thrombotic microangiopathy after stem cell transplant.
    Dandoy CE; Rotz S; Alonso PB; Klunk A; Desmond C; Huber J; Ingraham H; Higham C; Dvorak CC; Duncan C; Schoettler M; Lehmann L; Cancio M; Killinger J; Davila B; Phelan R; Mahadeo KM; Khazal S; Lalefar N; Vissa M; Myers K; Wallace G; Nelson A; Khandelwal P; Bhatla D; Gloude N; Anderson E; Huo J; Roehrs P; Auletta JJ; Chima R; Lane A; Davies SM; Jodele S
    Blood Adv; 2021 Jan; 5(1):1-11. PubMed ID: 33570619
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Risk and prognostic factors of transplantation-associated thrombotic microangiopathy in allogeneic haematopoietic stem cell transplantation: a nested case control study.
    Ye Y; Zheng W; Wang J; Hu Y; Luo Y; Tan Y; Shi J; Zhang M; Huang H
    Hematol Oncol; 2017 Dec; 35(4):821-827. PubMed ID: 27245857
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Transplant-associated thrombotic microangiopathy: Incidence, prognostic factors, morbidity, and mortality in allogeneic hematopoietic cell transplantation.
    Gavriilaki E; Sakellari I; Batsis I; Mallouri D; Bousiou Z; Vardi A; Yannaki E; Constantinou V; Tsompanakou A; Vadikoliou C; Kaloyannidis P; Bamihas G; Anagnostopoulos A
    Clin Transplant; 2018 Sep; 32(9):e13371. PubMed ID: 30080283
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Incidence, Risk Factors for and Outcomes of Transplant-Associated Thrombotic Microangiopathy.
    Epperla N; Li A; Logan B; Fretham C; Chhabra S; Aljurf M; Chee L; Copelan E; Freytes CO; Hematti P; Lazarus HM; Litzow M; Nishihori T; Olsson RF; Prestidge T; Saber W; Wirk B; Yared JA; Loren A; Pasquini M
    Br J Haematol; 2020 Jun; 189(6):1171-1181. PubMed ID: 32124435
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Renal arteriolar C4d deposition: a novel characteristic of hematopoietic stem cell transplantation-associated thrombotic microangiopathy.
    Laskin BL; Maisel J; Goebel J; Yin HJ; Luo G; Khoury JC; Davies SM; Jodele S
    Transplantation; 2013 Jul; 96(2):217-23. PubMed ID: 23698598
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Therapeutic Plasma Exchange does not Improve Renal Function in Hematopoietic Stem Cell Transplantation-Associated Thrombotic Microangiopathy: An Institutional Experience.
    Sartain S; Shubert S; Wu MF; Srivaths P; Teruya J; Krance R; Martinez C
    Biol Blood Marrow Transplant; 2019 Jan; 25(1):157-162. PubMed ID: 30144562
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Serious Hemorrhagic Complications After Successful Treatment of Hematopoietic Stem Cell Transplantation-Associated Thrombotic Microangiopathy With Defibrotide in Pediatric Patient With Myelodysplastic Syndrome.
    Laberko A; Aksenova M; Shipitsina I; Khamin I; Shcherbina A; Balashov D; Maschan A
    Front Pediatr; 2020; 8():155. PubMed ID: 32432059
    [No Abstract]   [Full Text] [Related]  

  • 36. [Allogeneic hematopoietic stem cell transplantation associated thrombotic microangiopathy: 16 cases report and literature review].
    Han W; Han Y; Chen J; Ma X; Chen F; Wu XJ; Qi JQ; Qiu HY; Sun AN; Wu DP
    Zhonghua Xue Ye Xue Za Zhi; 2016 Aug; 37(8):666-70. PubMed ID: 27587247
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Real-World Application of Recently Proposed ASTCT/CIBMTR/EBMT/APBMT Consensus Risk Stratification for Transplantation-Associated Thrombotic Microangiopathy in Children.
    Schoettler ML; Ofori J; Bryson E; Spencer K; Qayed M; Stenger E; Bidgoli A; Chonat S; Westbrook A; Williams KM
    Transplant Cell Ther; 2024 Sep; 30(9):929.e1-929.e6. PubMed ID: 38936547
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Defibrotide for Patients with Hepatic Veno-Occlusive Disease/Sinusoidal Obstruction Syndrome: Interim Results from a Treatment IND Study.
    Richardson PG; Smith AR; Triplett BM; Kernan NA; Grupp SA; Antin JH; Lehmann L; Shore T; Iacobelli M; Miloslavsky M; Hume R; Hannah AL; Nejadnik B; Soiffer RJ;
    Biol Blood Marrow Transplant; 2017 Jun; 23(6):997-1004. PubMed ID: 28285079
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Thrombotic Microangiopathy After Hematopoietic Stem Cell and Solid Organ Transplantation: A Review for Intensive Care Physicians.
    Nusrat S; Davis H; MacDougall K; George JN; Nakamura R; Borogovac A
    J Intensive Care Med; 2024 May; 39(5):406-419. PubMed ID: 37990516
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Complement blockade for TA-TMA: lessons learned from a large pediatric cohort treated with eculizumab.
    Jodele S; Dandoy CE; Lane A; Laskin BL; Teusink-Cross A; Myers KC; Wallace G; Nelson A; Bleesing J; Chima RS; Hirsch R; Ryan TD; Benoit S; Mizuno K; Warren M; Davies SM
    Blood; 2020 Mar; 135(13):1049-1057. PubMed ID: 31932840
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.